drug · small molecule
ifetroban
Phase 2updated 3mo agoby $CPIX CUMBERLAND PHARMACEUTICALS INC🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2 (across all indications), with 4 investigational indications.
indications
indications
Pulmonary FibrosisDuchenne Muscular Dystrophy
all catalysts(0)
nothing on the calendar yet
Trials studying ifetroban
- phase2Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
- phase2Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy
- phase2Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- phase2Thromboxane Receptor Antagonist to Improve Endothelial Function
- phase2Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)
- phase2Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic Recurrence
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 38m ago
Found something off?
comments(0)
5-min edit window · permanent after that